REG - Spire Healthcare Grp - Director/PDMR Shareholding

Spire HealthcareAnnouncement

19/06/2025 17:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250619:nRSS6521Na&default-theme=true

RNS Number : 6521N  Spire Healthcare Group PLC  19 June 2025

Spire Healthcare Group plc (the "Company")

19 June 2025

 

Notification of Transactions of Persons Discharging Managerial
Responsibilities

 

Grant of Long Term Incentive Plan (LTIP) awards

The Company announces that, on 19 June 2025, an additional performance share
award was granted over the Company's ordinary shares of 1 pence each (the
"Shares") in the form of nil cost options to the following Executive Director
of the Company, under the rules of the Company's Long Term Incentive Plan, to
reflect the recent change in his base salary that was disclosed in the 2024
Annual Report and Accounts.

 

Executive Director                Maximum number of Shares
under award

Harbant Samra                       28,729

 

The number of Shares set out above, together with the 436,681 awards granted
on 27 March 2025 (total number of 465,410 performance share awards in 2025)
represent 200% of the Executive Director's current base salary.  It is the
maximum number which may vest under the LTIP Awards following the end of the
performance period (31 December 2027).  The shareholder-approved Remuneration
Policy permits awards of up to 200% of base salary for Executive Directors.

 

The actual number of Shares which vest will depend on the extent to which the
relevant performance conditions have been satisfied.

 

The performance conditions applicable to the LTIP Awards will be based as
follows:

·    20% on relative total shareholder return (TSR) performance;

·    35% on ROCE performance;

·    15% on Hospital EBIT Margin performance; and

·    30% on two Operational Excellence measures.

 

Further details of these performance conditions were disclosed in the 2024
Annual Report and Accounts.

 

The share price used to determine the number of Shares under the LTIP awards
was 174.04 pence, the same share price used for the initial LTIP award, being
the average of the mid-market closing share price over the five trading days
ending on 26 March 2025. This is the same share price that was used to
determine the 2025 LTIP award for all participants.

 

Notes:

 

1)   For the Executive Director the 2025 LTIP awards described above will
also be subject to a further two-year holding period following the vesting
date.

2)   The actual number of shares which vest under the LTIP awards will
depend on the extent to which the relevant performance conditions are
satisfied in due course.

 

 

Name of contact and telephone number for queries:

Mantraraj Budhdev

Group General Counsel and Company Secretary

Spire Healthcare Group plc

Tel: 07787 283848

 

 

The information set out below is provided in accordance with the requirements
of the UK Market Abuse Regulation.

 

Notification and public disclosure of transaction by persons discharging
managerial responsibility and persons closely associated with them

 

 a)  Name                                                         Harbant Samra

 2   Reason for the notification
 a)  Position/status                                              Chief Financial Officer

 b)  Initial notification /Amendment                              Initial notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Spire Healthcare Group plc

 b)  LEI                                                          213800IBJPW3SE2RA350

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BNLPYF73
 b)  Nature of the transaction                                    Grant of performance share awards under the Company's Long Term Incentive Plan
 c)  Price(s) and volume(s)                                       Price(s)                                  Volume(s)
                                                                  Nil                                       28,729

 d)  Aggregated information                                       As above

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      2025-06-19
 f)  Place of the transaction                                     Outside of trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBLGDLCGBDGUC